Open access · CC-BY
via OpenAlex
An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors
Jamaji C. Nwanaji‐Enwerem, Felicia Fei‐Lei Chung, Lars W. P. van der Laan, Alexei Novoloaca, Cyrille Cuenin, Harriet Ann Johansson, Bernardo Bonanni, Alan Hubbard, Martyn T. Smith, Sheri J. Hartman, Andrés Cárdenas, Dorothy D. Sears, Zdenko Herceg
Clinical Epigenetics · 2021 · ▲ 19 citations
Abstract
Metformin and weight loss relationships with epigenetic age measures-biological aging biomarkers-remain understudied. We performed a post-hoc analysis of a randomized controlled trial among overweight/obese breast cancer survivors (N = 192) assigned to metformin, placebo, weight loss with metformin, or weight loss with placebo interventions for 6 months. Epigenetic age was correlated with chronological age (r = 0.20-0.86; P < 0.005). However, no significant epigenetic aging associations were observed by intervention arms. Consistent with published reports in non-cancer patients, 6 months of metformin therapy may be inadequate to observe expected epigenetic age deceleration. Longer duration studies are needed to better characterize these relationships.Trial Registration: Registry Name: ClincialTrials.Gov.Registration Number: NCT01302379.Date of Registration: February 2011.URL: https://clinicaltrials.gov/ct2/show/NCT01302379.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13148-021-01218-y
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Nwanaji‐Enwerem, J.C., Chung, F.F., Laan, L.W.P.V.D., Novoloaca, A., Cuenin, C., Johansson, H.A., Bonanni, B., Hubbard, A., Smith, M.T., Hartman, S.J., Cárdenas, A., Sears, D.D., & Herceg, Z. (2021). An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors. <em>Clinical Epigenetics</em>. https://doi.org/10.1186/s13148-021-01218-y
Vancouver
Nwanaji‐Enwerem JC, Chung FF, Laan LWPVD, Novoloaca A, Cuenin C, Johansson HA, et al. An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors. Clinical Epigenetics. 2021. doi:10.1186/s13148-021-01218-y.
BibTeX
@article{jamaji2021Anepig,
title = {An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors},
author = {Jamaji C. Nwanaji‐Enwerem and Felicia Fei‐Lei Chung and Lars W. P. van der Laan and Alexei Novoloaca and Cyrille Cuenin and Harriet Ann Johansson and Bernardo Bonanni and Alan Hubbard and Martyn T. Smith and Sheri J. Hartman and Andrés Cárdenas and Dorothy D. Sears and Zdenko Herceg},
journal = {Clinical Epigenetics},
year = {2021},
doi = {10.1186/s13148-021-01218-y},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
medRxiv 2026
Open access · OA
Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial
Springer eBooks 2009
Citation only
Epigenetic Drift and Aging
Cell Metabolism 2013
Open access · OA
Metformin, Microbes, and Aging
Trends in Immunology 2015
Citation only
Senescence-associated inflammatory responses: aging and cancer perspectives
Journal of the National Cancer Institute 2026
Citation only
Exercise slows biological aging in breast cancer survivors: secondary analysis of a randomized trial.
Journal for ReAttach Therapy and Developmental Diversities 2022
Open access · OA